Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
State Street Corp reported a 5.30% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.30% stake in Syndax Pharmaceuticals, Inc., 4,596,552 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 4,596,552
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.30% | 4,596,552 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- State Street Corp
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026